187 related articles for article (PubMed ID: 37704431)
1. Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study.
Nakao K; Noguchi T; Miura H; Asaumi Y; Morita Y; Takeuchi S; Matama H; Sawada K; Doi T; Hosoda H; Nakashima T; Honda S; Fujino M; Yoneda S; Kawakami S; Nagai T; Nishihira K; Kanaya T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Kusano K; Yamamoto H; Omae K; Ogawa H; Yasuda S
J Atheroscler Thromb; 2024 Feb; 31(2):122-134. PubMed ID: 37704431
[TBL] [Abstract][Full Text] [Related]
2. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S
Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688
[TBL] [Abstract][Full Text] [Related]
3. Effect of Omega-3 Fatty Acids on Coronary Plaque Morphology - A Serial Computed Tomography Angiography Study.
Motoyama S; Nagahara Y; Sarai M; Kawai H; Miyajima K; Sato Y; Matsumoto R; Takahashi H; Naruse H; Ishii J; Ozaki Y; Izawa H
Circ J; 2022 Apr; 86(5):831-842. PubMed ID: 34776470
[TBL] [Abstract][Full Text] [Related]
4. Effect of Intensive Statin Therapy on Coronary High-Intensity Plaques Detected by Noncontrast T1-Weighted Imaging: The AQUAMARINE Pilot Study.
Noguchi T; Tanaka A; Kawasaki T; Goto Y; Morita Y; Asaumi Y; Nakao K; Fujiwara R; Nishimura K; Miyamoto Y; Ishihara M; Ogawa H; Koga N; Narula J; Yasuda S
J Am Coll Cardiol; 2015 Jul; 66(3):245-256. PubMed ID: 26184618
[TBL] [Abstract][Full Text] [Related]
5. An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment.
Alfaddagh A; Elajami TK; Saleh M; Mohebali D; Bistrian BR; Welty FK
Atherosclerosis; 2019 Jun; 285():153-162. PubMed ID: 31055222
[TBL] [Abstract][Full Text] [Related]
6. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
Hariri E; Asbeutah AA; Malik A; Amangurbanova M; Chedid G; Daher R; Al Hammoud M; Welty FK
Atherosclerosis; 2023 Dec; 387():117388. PubMed ID: 38056242
[TBL] [Abstract][Full Text] [Related]
8. Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study.
Kita Y; Watanabe M; Kamon D; Ueda T; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Inoue F; Doi N; Okura H; Uemura S; Saito Y
J Am Heart Assoc; 2020 Aug; 9(16):e015593. PubMed ID: 32805184
[TBL] [Abstract][Full Text] [Related]
9. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
Chapman MJ; Zamorano JL; Parhofer KG
Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
[TBL] [Abstract][Full Text] [Related]
10. Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy.
Urabe Y; Yamamoto H; Kitagawa T; Utsunomiya H; Tsushima H; Tatsugami F; Awai K; Kihara Y
Circ J; 2013; 77(10):2578-85. PubMed ID: 23863750
[TBL] [Abstract][Full Text] [Related]
11. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
12. Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients.
Crandell JR; Tartaglia C; Tartaglia J
Postgrad Med; 2016 Nov; 128(8):859-864. PubMed ID: 27684412
[TBL] [Abstract][Full Text] [Related]
13. Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues.
Sherratt SCR; Libby P; Budoff MJ; Bhatt DL; Mason RP
Curr Atheroscler Rep; 2023 Jan; 25(1):1-17. PubMed ID: 36580204
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 Fatty Acids Reduce Remnant-like Lipoprotein Cholesterol and Improve the Ankle-Brachial Index of Hemodialysis Patients with Dyslipidemia: A Pilot Study.
Kobayashi Y; Fujikawa T; Haruna A; Kawano R; Ozawa M; Haze T; Komiya S; Suzuki S; Ohki Y; Fujiwara A; Saka S; Hirawa N; Toya Y; Tamura K
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256336
[No Abstract] [Full Text] [Related]
15. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.
Budoff M; Brent Muhlestein J; Le VT; May HT; Roy S; Nelson JR
Clin Cardiol; 2018 Jan; 41(1):13-19. PubMed ID: 29365351
[TBL] [Abstract][Full Text] [Related]
16. Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides.
Kedia AW; Lynch E
Postgrad Med; 2015; 127(8):869-73. PubMed ID: 26453247
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid.
John Chapman M; Preston Mason R
Pharmacol Ther; 2022 Dec; 240():108237. PubMed ID: 35772589
[TBL] [Abstract][Full Text] [Related]
18. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
Budoff MJ; Muhlestein JB; Bhatt DL; Le Pa VT; May HT; Shaikh K; Shekar C; Kinninger A; Lakshmanan S; Roy SK; Tayek J; Nelson JR
Cardiovasc Res; 2021 Mar; 117(4):1070-1077. PubMed ID: 32609331
[TBL] [Abstract][Full Text] [Related]
19. Potential benefits of eicosapentaenoic acid on atherosclerotic plaques.
Nelson JR; Wani O; May HT; Budoff M
Vascul Pharmacol; 2017 Apr; 91():1-9. PubMed ID: 28263852
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis Comparing the Effect of Combined Omega-3 + Statin Therapy Versus Statin Therapy Alone on Coronary Artery Plaques.
Fan H; Zhou J; Yuan Z
Am J Cardiol; 2021 Jul; 151():15-24. PubMed ID: 34049675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]